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Abstract
 
Although elevated levels of IgE in asthmatic patients are strongly associated with lung infiltration
by activated T helper (Th) 2 cells, the physiological role of immunoglobulin E (IgE) in the airway
 
remains largely undefined. Lymphotoxin-deficient 
 
 
 
 (LT
 
 
 
 
 
/
 
 
 
) mice exhibit increased airway
inflammation, paradoxically accompanied by diminished levels of IgE and reduced airway hyper-
responsiveness in response to both environmental and induced antigen challenge. The severe
 
lung inflammation in LT
 
 
 
 
 
/
 
 
 
 mice is Th1 in nature and can be alleviated by IgE reconstitution.
Conversely, depletion of IgE in wild-type mice recapitulates the lung pathologies of LT
 
 
 
 
 
/
 
 
 
mice. Therefore, this work has revealed that lymphotoxin is essential for IgE production, and a
physiological role of IgE in the airway may consist of maintaining the balance of Th1 and Th2
responses to prevent aberrant inflammation.
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Introduction
 
Several papers have shown that the development of bron-
chial asthma is associated with elevated IgE levels, the
predominance of Th2 cytokine production, and eosinophilic
inflammation of the airways (1–4). In addition to clinical
correlations of asthma with high IgE levels, genetic analyses
of families with asthma have also revealed a link between
bronchial hyperresponsiveness (BHR) and high IgE levels
(5, 6). Allergen-linked IgE signaling participates in the
initiation of immediate hypersensitivity reactions and BHR
by triggering mast cell degranulation (3, 7, 8). Allergens
 
trigger mast cells by cross-linking surface Fc
 
 
 
RI-bound
IgE, resulting in the release of IL-4, IL-13, and other factors,
and ultimately promoting a Th2 response and allergic airway
inflammation (9–13). Moreover, reduced expression of
T-bet, a transcription factor for Th1 cytokines, induces a
phenotype of murine asthma analogous to both acute and
chronic human asthma, thus providing further support for
the necessity of an optimal balance between Th1 and Th2
 
to maintain lung homeostasis and prevent aberrant inflam-
 
mation. (10). In contrast to the data that Th2-mediated
inflammation is dominant in allergen-induced asthma,
several papers have shown surprisingly that the addition of
allergen-specific Th1 cells can exacerbate airway inflam-
mation (11–13). To control moderate-to-severe allergic
asthma, humanized monoclonal antibodies directed against
IgE have been used for treatment, but their efficacy is
rather limited (14, 15). Surprisingly, IgE may not be essential
for allergen-induced BHR and airway inflammation (16);
thus far, the physiological role of IgE in the airway has
not been demonstrated.
Lymphotoxin (LT) 
 
 
 
 has been identified in two molecular
 
forms as follows: a secreted form consisting of an LT
 
 
 
3
 
homotrimer that binds to TNF receptors and a membrane-
associated heterotrimeric form with LT
 
  
 
2
 
 that binds to
LT
 
 
 
R. LT
 
 
 
-deficient (LT
 
 
 
 
 
/
 
 
 
) and LT
 
 
 
R
 
 
 
/
 
 
 
 mice lack
LNs but show a spontaneous accumulation of a diverse
repertoire of immune cells in the lungs. The mechanisms
underlying this spontaneous accumulation have not been
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 BAL, bronchoalveolar lavage; BHR, bronchial
hyperresponsiveness; i.t., intratracheally; LT, lymphotoxin; SEA, 
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mansoni
 
 egg antigen. 
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adequately addressed (17–19). It is curious that LT
 
 
 
 
 
/
 
 
 
mice have a strong inflammatory response to antigen chal-
lenge in the airway, even in the absence of draining LNs
(20, 21). Here, we report that the infiltrating cells are ac-
tively participating in airway inflammation, and their accu-
mulation in the lung can be paradoxically attributed to di-
minished serum IgE levels in LT
 
 
 
 
 
/
 
 
 
 mice. Therefore, our
results uncover a hitherto unappreciated physiological role
of IgE in the protection of the airway from inappropriate
inflammation and BHR.
 
Materials and Methods
 
Mice. 
 
LT
 
 
 
 
 
/
 
 
 
 and LT
 
 
 
R
 
 
 
/
 
 
 
 mice were backcrossed to
C57BL/6 mice and maintained under specific pathogen-free con-
ditions as described previously (18, 22). TNF
 
 
 
/
 
 
 
 and C57BL/6
mice were purchased from the Jackson Laboratory. LT
 
 
 
R
 
 
 
/
 
 
 
mice were obtained from Taconic Farms. Animal care and use
were in accordance with institutional and National Institutes of
Health guidelines.
 
Histology. 
 
Lung tissues for histological examination were
fixed in 10% buffered formalin. Lung tissues of IgE
 
 
 
/
 
 
 
 mice were
 
Figure 1.
 
Increased inflammation and airway
remodeling in LT
 
 
 
 
 
/
 
 
 
 and IgE
 
 
 
/
 
 
 
 mice. (A)
Lung tissues from WT, LT
 
 
 
 
 
/
 
 
 
, and IgE
 
 
 
/
 
 
 
mice (3 mo old) were fixed in 10% buffered
formalin and embedded in paraffin. Hematoxylin
and eosin staining (top, H&E) and Masson’s
trichrome staining (bottom) of B6, LT
 
 
 
 
 
/
 
 
 
,
and IgE
 
 
 
/
 
 
 
 mice are presented. (B) The lung
(left) and BAL cells (right) were isolated by
collagenase digestion and lavage, respectively,
from 3-mo-old B6 (white bars) and LT
 
 
 
 
 
/
 
 
 
(black bars) mice (
 
n
 
 
 
  
 
5 per group). The total
number of cells was analyzed with trypan blue
staining. The number of leukocytes in the lung
of LT
 
 
 
 
 
/
 
 
 
 mice is significantly higher than that
of the WT (P 
 
  
 
0.001). BAL cells from five
mice were pooled for further analysis by
FACS
 
®
 
. (C) Lung cells were dually stained with
FITC-conjugated anti-CD69 and PE-conjugated
anti-CD3. The fluorescence intensity was ana-
lyzed from the gated lymphocyte population of
B6 (left) and LT
 
 
 
 
 
/
 
 
 
 (right) mice. The per-
centage of CD69
 
 
 
 cells among CD3
 
 
 
 cells is
presented. (D) The forward/side scatter dot-plot
profiles were analyzed from BAL cells of B6
(left) and LT
 
 
 
 
 
/
 
 
 
 (right) mice; (a), (b), and (c)
represent the lymphocyte, granulocyte, and
macrophage population, respectively. (E) The
gated lymphocyte population (a) from the
forward/side scatter dot-plot profiles of BAL
cells (D) was analyzed for CD4 and B220 ex-
pression by FACS
 
®
 
 analysis. (F) CCR3 and
CD3 expression was analyzed from both the
gated lymphocyte (a) and granulocyte (b) popu-
lations. (G) The type of BAL cells was deter-
mined by calculating the absolute number of
each cell type from the FACS
 
®
 
 profiles and by
the total number of cells (P 
 
  
 
0.0001; WT vs.
LT
 
 
 
 
 
/
 
 
 
).  
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provided by H. Oettgen (Boston Children’s Hospital, Boston,
MA). 3-
 
 
 
m sections were obtained from the paraffin blocks and
stained using both the hematoxylin and eosin and Masson’s
trichrome staining methods. All sections were examined qualita-
tively by an experienced pathologist in a blind fashion.
 
Flow Cytometric Analysis. 
 
All antibodies for flow cytometric
analysis were purchased from BD Biosciences. Bronchoalveolar
lavage (BAL) and lung cells were incubated in Fc-block, 2.4G2,
for 20 min, stained in PBS containing 1% FBS (GIBCO BRL)
plus 0.01% NaN
 
3
 
 for 30 min on ice, and analyzed by flow cytom-
etry on a FACScan™ (BD Biosciences). For statistical analysis,
p-values were determined by two-tailed Student’s 
 
t
 
 test. For intra-
cellular cytokine staining, lung cells were obtained by collagenase
digestion and stimulated with 50 ng/ml PMA, 500 ng/ml iono-
mycin, and 10 
 
 
 
g/ml Brefelden A in complete RPMI 1640 me-
dia with 10% FCS for 6 h at 37
 
 
 
C, 5% CO
 
2
 
. Extracellular staining
was performed using anti–CD4-PE for 30 min on ice. The cells
were fixed with 2% paraformaldehyde. For intracellular staining,
cells were permeabilized with 0.5% saponin in PBS, stained with
either IL-4–allophycocyanin or IFN
 
 
 
-allophycocyanin in perme-
abilization buffer, and analyzed by FACS
 
®
 
.
 
Isolation of Lung Leukocytes and BAL Cells. 
 
Lung tissues were
digested three times by shaking (175 revolutions/min) for 30 min
at 37
 
 
 
C in RPMI 1640 medium containing 1.5 mg/ml collage-
nase VIII and 2% FBS. Lung cells were passed through a nytex
filter. Bronchial lavage was performed by delivering 1 ml of cold
RPMI 1640 containing 2% FBS into the trachea and gently aspi-
rating the fluid. The first lavage was centrifuged, and supernatant
was stored at 
 
 
 
20
 
 
 
C for cytokine analysis by ELISA. Lavage was
repeated three times, and cells collected from each wash were
pooled for FACS
 
®
 
 analysis.
 
Cytokine
 
 
 
and IgE ELISA. 
 
The lung tissue was homogenized
in 500 
 
 
 
l PBS containing protease inhibitors. The lysate was col-
lected by centrifugation at 12,000 revolutions/min for 15 min.
Cytokine production from the lung lysate and BAL fluid was
measured by ELISA. The total IgE concentration from the serum
 
(
 
n
 
 
 
  
 
9) was measured by ELISA according to the manufacturer’s
protocol (BD Biosciences).
 
Respiratory Mechanics. 
 
Assessment of cholinergic airway con-
strictor responsiveness was done with a computer-controlled
small-animal ventilator (Flexivent; SCIREQ). In brief, the mice
were anesthetized with 0.1 ml per 10 g body weight of a mixture
containing 2 mg/ml xylazine and 40 mg/ml ketamine hydrochlo-
ride given i.p. Anesthesia was maintained by supplemental ad-
ministration of 30% of the initial dose at 
 
 
 
25-min intervals, as
required. Heart rate was monitored by EKG with needle elec-
trodes. After tracheostomy, the trachea was cannulated with a
blunted 18-gauge metal needle. The mouse was quasi-sinusoi-
dally ventilated with a nominal tidal volume of 10 ml/kg at a fre-
quency of 150 breaths/min and a positive end-expiratory pressure
of 2 cm H
 
2
 
O. To determine the differences in airway response to
methacholine between WT and LT
 
 
 
 
 
/
 
 
 
 mice, each mouse was
challenged with seven doses of methacholine aerosol (0, 0.1, 1, 5,
10, 20, and 40 mg/ml in saline) for 12 s. Before each aerosol
challenge, the animal was given two deep inspirations to stan-
dardize volume history. After each methacholine challenge, respi-
ratory system resistance was recorded during tidal breathing every
10 s for 2 min, and the peak resistance was selected as the bron-
choconstrictor response to that methacholine dose. Analysis of
variance is used to analyze the differences in airway response to
methacholine between WT and LT
 
 
 
 
 
/
 
 
 
 mice.
 
Schistosoma mansoni Egg Antigen (SEA) Sensitization and Chal-
lenge. 
 
Mice were sensitized i.p. on day 0 with 2.5 
 
 
 
 10
 
3
 
 inacti-
vated 
 
S. mansoni
 
 eggs. On day 7, the mice were challenged in-
tratracheally (i.t.) with 50 
 
 
 
g of soluble SEA. 4 d after challenge,
mice were killed, BAL was collected, and lungs were dissected for
digestion. Strong Th2-dominant airway inflammation with 70–
90% eosinophils in BAL could be detected after challenge (23,
24). In IgE reconstitution experiments, LT
 
  /  mice were in-
jected i.p. on days  21,  14, and  7 with either mouse Ig or
polyclonal IgE purified from WT mice. S. mansoni sensitization
on day 0, SEA challenge on day 7, and harvest on day 11 were
(H) B6 and LT  /  mice were analyzed by
three-color staining with FITC–anti-B220,
cychrome–anti-CD4, and PE–anti-CD8 or PE–
anti-NK1.1. The gated lymphocyte population
(a) from the forward/side scatter dot-plot profiles
of the lung cells was analyzed for CD4 and
B220 (P   0.01, WT vs. LT  /  mice). The
percentage of CD8  or NK1.1  cells gated
from B220 CD4  was evaluated. (I) CCR3
and CD3 expression was analyzed from both
the gated lymphocyte (a) and granulocyte (b)
population. (J) The total number of cells was
calculated. The type of lung cells was also deter-
mined by calculating the absolute number of each
cell type from the FACS® profiles. The results are
representative of five independent experiments.IgE Is Required for Airway Homeostasis 1646
performed as described in Fig. 4. In IgE depletion experiments,
B6 mice were injected i.p. on days  21,  14, and  7 with 30
 g of either rat Ig or anti-IgE antibodies as follows: EM95 or
R1E4 (8, 25). All reagents were free of endotoxin (EU   0.25).
Results
Increased Airway Inflammation and Remodeling in LT  / 
Mice.  To carefully determine the nature of the previously
reported accumulation of leukocytes in the lungs of LT  / 
mice (17–19), detailed histopathological analysis was per-
formed. The lungs of LT  /  mice do not merely harbor
leukocytes but gradually develop a chronic airway inflam-
mation that worsens with age (Fig. 1 A). The infiltration
consists of mainly mononuclear cells predominantly in
the peribronchial and perivascular areas. Histopathological
analysis of lung tissues in LT  /  mice also revealed signif-
icant airway remodeling. These changes include bronchial
wall thickening, subepithelial fibrosis, increased goblet cell
mass, myoblast–myocyte hyperplasia and hypertrophy, epi-
thelial cell hypertrophy, and increased deposition of col-
lagen below the basement membrane; these are all clear in-
dicators of chronic airway inflammation. Furthermore, the
thickness of this subepithelial collagen layer was visualized
by Masson’s trichrome staining, which stains collagen. In
naive LT  /  mice, the collagen layer under the basement
membrane was much thicker than that of WT mice (Fig. 1
A). To further determine the type and number of infiltrat-
ing cells in the lung tissue, lungs from WT and LT  / 
mice were digested with collagenase. The suspension of
cells was analyzed by flow cytometry and a three- to five-
fold increase in total cell number was found in LT  / 
mice (Fig. 1 B) with an increased proportion of activated T
cells, as measured by CD69 expression, in LT  /  mice
compared with WT mice (Fig. 1 C). Thus, LT  /  mice,
without deliberate challenge, appear to develop a sponta-
neous, cumulative airway inflammation with active remod-
eling not seen in WT mice housed in the same specific
pathogen-free facility.
To more closely define the inflammation in the airway,
BAL cells were collected from WT and LT  /  mice and
analyzed. An increase in total BAL cells was also found in
LT  /  mice (Fig. 1 B), corresponding to escalating infil-
tration in the lung tissue. More impressively, LT  /  mice
had a much higher percentage of BAL lymphocytes than
WT mice as determined by flow cytometry (Fig. 1 D, area
a, 6.7   0.8% in WT mice, 70.2   1.6% in LT  /  mice).
These results were consistent with differential cell counts
from cytospin preparations of BAL (unpublished data).
CD4  T and B cells were the major subsets of the in-
creased lymphocyte population in LT  /  BAL (Fig. 1, E
and G). The percentage of CD8  T cells was also in-
creased, and NK1.1  cells were reduced (Fig. 1 H). The
forward/side scatter dot-plot profile of WT and LT  / 
BAL cells also showed a reduction in the granulocyte pop-
ulation in LT  /  mice (Fig. 1 D, area b, 8.3% in WT
mice, 2.8% in LT  /  mice). CCR3 is a   chemokine re-
ceptor found predominantly, but not exclusively, on eo-
sinophils (26, 27). To determine whether LT  /  mice
present with eosinophilia, cells from the BAL were stained
with an anti-CCR3 antibody, and the number of CCR3
positive cells was reduced in airways of LT  /  (Fig. 1 F,
22   1.3% in WT mice, 7   0.4% in LT  /  mice). This
result was consistent with the reduced percentage of eo-
sinophils in LT  /  mice determined by cytospin; however,
the total number of eosinophils was not reduced (unpub-
lished data). Although the absolute cell numbers of CD4-
and B220-expressing cells were markedly increased in the
BAL of LT  /  mice compared with WT mice ( 30- and
80-fold, respectively), the number of macrophages re-
mained unperturbed (Fig. 1 G). Similarly to the BAL, the
percentages of CD4-, CD8-, and B220-expressing cells in
the lungs of LT  /  mice were increased (Fig. 1 H). Be-
cause the total number of leukocytes in the lung increased
significantly (P   0.0001), the actual total number of CD4,
CD8, and B220+ cells increased an impressive 8–14 fold.
The percentage of NK cells and CCR3  cells was greatly
reduced, and the absolute number of these cells was also
slightly reduced in the lung of LT  /  mice (Fig. 1, I and
J). Together, these observations implied that the profound
increase of total cell numbers in the airways of LT    
mice was largely due to the increased infiltration of lym-
phocytes, a feature of chronic inflammation.
Interaction between LT and Its Receptor Is Required for IgE
Production.  Increased airway inflammation is often asso-
ciated with elevated serum IgE concentrations. Despite the
increased airway inflammation in naive LT  /  mice, un-
expectedly we found IgE concentrations reduced to nearly
undetectable levels (Fig. 2). LT  /  mice lack both solu-
ble and membrane LT. Either membrane or soluble LT
could be required for IgE production; therefore, the sera
from LT  /  mice were collected. These mice, which
lack only the membrane form of LT, also have low IgE
levels. To better define the receptor involvement, serum
from LT R /  mice was collected and found to share the
IgE defect observed in LT  /  mice, thus identifying a
new ligand and receptor pair required for IgE production.
Interestingly, TNF, another closely related cytokine that
shares the same receptors as soluble LT, is dispensable for
IgE production (Fig. 2). These data revealed the presence
Figure 2. LT is required for IgE production. The sera from various 12–16-
wk-old LT  /  mice (n   9) were collected, and total IgE concentration
was measured by ELISA. Data represent the mean   SE.Kang et al. 1647
of membrane LT and its receptor, LT R / , are critical
for IgE production.
Mice Deficient in IgE Also Develop Airway Inflammation.
Antigen-induced bronchial hyperreactivity and eosino-
philic inflammation can occur in the absence of IgE in a
mouse model of asthma, but whether there is an increase of
airway inflammation without deliberate challenge had not
been shown (16). Fixed lung tissues of IgE /  mice were
obtained and showed a chronic airway inflammation by
3–4 mo of age (Fig. 1 A). The infiltration mainly consisted
of mononuclear cells, predominantly in the peribronchial
and perivascular areas in a pattern similar to LT  /  mice.
Further histopathological analysis of IgE /  lung tissues re-
vealed bronchial wall thickening, subepithelial fibrosis, in-
creased goblet cell mass, myoblast–myocyte hyperplasia and
hypertrophy, epithelial cell hypertrophy, and increased
deposition of collagen below the basement membrane. In
fact, 6-mo-old BCR /  mice have also increased infiltra-
tion in both the perivascular and peribronchial areas (un-
published data). Together, these data show that naive IgE / 
mice, similar to the LT  /  mice, had increased airway in-
flammation compared with WT controls, which supports
the importance of maintaining appropriate IgE levels for
airway homeostasis.
The Airway Inflammation of LT  /  Mice Is Characterized
by an Increased Th1 Response. To study the cytokine pro-
file of the lung and BAL of LT  /  mice, first we mea-
sured the levels of IFN- , a prototypic cytokine for a Th1
response. The levels of IFN- , in both the lung and BAL
of LT  /  mice were markedly higher than those of WT
mice in the absence of active challenge (Fig. 3 A). Despite
the increased T cell infiltration in their lungs, LT  / 
mice have reduced Th2 cytokines, represented by a dra-
matic reduction of IL-5 on a per–T cell basis (Fig. 3 B).
IL-4 levels in the BAL of LT  /  mice were also reduced
profoundly (2.5   0.8 pg/ml vs. 11   1.8 pg/ml of WT
Figure 3. LT  /  airways display a Th1 phe-
notype even after a strong Th2 antigen challenge.
The lung tissues from B6 and LT  /  mice
(n    3–5 per group) were homogenized in
PBS containing proteinase inhibitors, and the
supernatants were collected by centrifugation.
Cytokines from the BAL were measured after a
1-ml flushing of the airways through the trachea.
IFN-  (A) and IL-5 (B) levels were measured
by ELISA from the lung lysates (left) and BAL
fluids (right). (C and D) B6 and LT  /  mice
were sensitized i.p. on day 0 with 5   103 inac-
tivated soluble S. mansoni egg antigen (SEA).
On day 7, the mice were challenged i.t. with
SEA. On day 11, mice were killed, and cytokines
from the lung and BAL were analyzed. The
lung lysates and BAL fluids of those mice were
subjected to ELISA. IFN-  (C) and IL-5 (D)
levels are shown (P   0.05). Data represent the
mean   SD from a representative experiment.
Experiments were repeated four times by different
individuals with similar results. For intracellular
staining, lung cells (E) and splenocytes (F) were
collected and stimulated as described in Materials
and Methods. Extracellular staining was per-
formed using anti–CD4-PE, and intracellular
staining was performed using either IL-4–allo-
phycocyanin or IFN -allophycocyanin.IgE Is Required for Airway Homeostasis 1648
mice; P   0.001). Together, these data suggest a deliberate
Th1-type inflammation.
Stimulation of the airway with allergen may stimulate
IgE-bound cells to release an initial burst of cytokines, such
as IL-4, which bias the initial response to Th2 (9, 28). In-
tratracheal challenge of WT mice with SEA, subsequent to
priming with S. mansoni eggs, results in a robust Th2-medi-
ated lung inflammation (23, 24). To determine whether
this Th2-skewing model of airway inflammation could de-
viate the T cell response in LT  /  mice, LT  /  mice
were primed and challenged with SEA. LT  /  mice de-
velop a much more severe airway inflammation in response
to SEA challenge than WT mice (4.6   0.4   106 cells in
BAL and 52   4.3   106 cells in the lung of LT  /  mice
vs. 1.8   0.2   106 in BAL and 16   3   106 in the lung
of WT mice; P   0.001). This response remains character-
ized by Th1 polarization including increased IFN-  and re-
duced IL-4 or IL-5 in response to SEA (Fig. 3, C and D).
To determine whether the altered cytokine patterns are as-
sociated with an increased Th1/Th2 ratio in the lung of
naive LT  /  mice, intracellular staining of anti–IFN- 
and IL-4 in combination with T cell markers was per-
formed (Fig. 3, E and F). Clearly, increased IFN-  and re-
duced IL-4 from CD4  T cells in LT  /  mice were also
demonstrated. Therefore, the preexisting milieu in the
lungs of LT  /  mice, conditioned by reduced IgE levels,
not only resists deviation to a Th2-mediated response, but
also exacerbates the overall Th1 inflammatory reaction. To
study whether such altered cytokine patterns were specific
to the lung, intracellular cytokines of lymphocytes from the
spleen of WT mice and LT  /  mice were studied. Inter-
estingly, cytokine profiles in the spleen were unchanged
(Fig. 3 F). These data suggest that the altered cytokine pat-
terns might not be systemic but limited to the lung mi-
croenvironment.
IgE Reconstitution Reverses Th1-dominant Airway Inflamma-
tion in LT  /  Mice.  LT  /  mice exhibit multiple de-
fects in addition to IgE deficiency; for example, their ab-
sence of LNs, which may contribute to the increase of
infiltrates in the lungs (17, 18, 29). To circumvent the
numerous defects associated with LT  /  and define the
relevant contribution of IgE, 12-wk-old LT  /  mice
with spontaneous airway inflammation were reconstituted
with polyclonal purified murine IgE. After three infusions
(once a week for 3 wk), serum IgE concentrations in re-
constituted LT  /  mice peaked at 30–50% of WT levels.
When compared with control murine Ig treatments or no
treatment, this short-term IgE reconstitution resulted in a
Figure 4. IgE reconstitution
of LT  /  mice results in the
reduction of the total cell number
and a shift from a Th1 to Th2
cytokine profile in the lung and
BAL cells. (A) LT  /  mice (n  
3) were treated i.p. with 500 ng
of mouse Ig or purified IgE once
per week for 3 wk. 1 wk after
the last treatment, the total
number of cells in the lung and
BAL of B6, mIg-, or IgE-treated
LT  /  mice were analyzed by
trypan blue staining. IgE-reconsti-
tuted LT  /  mice have similar
total cell numbers compared
with control mice (P    0.01).
(B) Reconstituted LT  /  have
reduced leukocytes in the BAL
and lung compared with control
treated mice (P   0.01). The cell
number was determined by cal-
culating the total number of cells
and the absolute number of each
cell type from the FACS® profile.
IFN-  and IL-5 levels were deter-
mined by ELISA from BAL fluids
of mIg- or purified IgE-treated
LT  /  mice. (P   0.05; IgE vs.
mIg). (C) LT  /  mice (n   3)
were injected i.p. with either
500 ng mouse Ig or purified IgE
on day  21,  14, and  7. On
day 0, mice were injected with either mIg or IgE and sensitized i.p. with 2.5   103 inactivated S. mansoni eggs. On day 7, the mice were challenged i.t.
with 50  g SEA. On day 11, mice were killed and analyzed for the total number of cells in BAL and digested lung (P   0.01; IgE vs. mIg). (D) The type
of cells present in the BAL of SEA-challenged and mIg- or IgE-reconstituted LT  /  mice was determined by calculating the total number of cells and
the absolute number of each cell type from the FACS® profiles. IFN-  and IL-5 levels were measured from BAL fluids of SEA-challenged and mIg- or
IgE-reconstituted LT  /  mice (P   0.001 for IFN- ; P   0.05 for IL-5; IgE vs. mIg). Data represent the mean   SD from a representative experiment.
Experiments were repeated four times by different individuals with similar results.Kang et al. 1649
remarkable reduction of cell infiltration in the lung and
BAL of LT  /  mice, predominantly in the CD4  and
macrophage population (Fig. 4 A). To further test whether
reconstitution of IgE in LT  /  mice depolarizes the es-
tablished Th1 microenvironment in addition to alleviating
the cellular infiltration, Th1/Th2 cytokine profiles were
analyzed. IFN-  levels in the BAL fluid of IgE-reconsti-
tuted LT  /  mice were reduced to undetectable levels,
whereas IL-5 increased dramatically (Fig. 4 B). Consis-
tently, IL-4 levels in BAL fluid in IgE-reconstituted LT  / 
mice were also restored to the level of WT mice (8.6  
1.3 pg/ml in reconstituted group; 2.2   0.8 pg/ml in con-
trol-treated group). After SEA challenge, the total cell
number and cytokine profiles of IgE-reconstituted mice
matched that of WT mice, in both the lung and the BAL
(Fig. 4, C and D). IgE reconstitution in LT  /  mice re-
duced their airway inflammation and restored the WT Th2
response, implicating IgE deficiency in LT  /  mice as the
central defect responsible for the Th1 airway inflammation
in the lungs.
Recapitulation of Th1-dominant Airway Inflammation in WT
Mice by Depletion of IgE.  To further define the impor-
tance of IgE in the airway inflammation, we determined
whether reduced IgE in WT mice can sufficiently recapitu-
late the airway inflammation seen in LT  /  mice. To de-
plete IgE, WT mice were treated with mAb against mouse
IgE (EM95), once a week for 3 wk. The serum, lung, and
BAL cells of the IgE-depleted mice were collected and an-
Figure 5. Increased cell number and altered cytokine
production in the lung and BAL cells of IgE-depleted
WT mice. (A) B6 mice (n   3) were treated i.p. with
50  g of rat Ig or anti-IgE (EM95) once per week for
3 wk. 1 wk after the last treatment, the total number of
cells in the lung and BAL was analyzed (P   0.01;
EM95 vs. control group). (B) IFN-  and IL-4 levels
were determined by ELISA in BAL fluids from B6
mice treated with either rat Ig or anti-IgE (P   0.05;
EM95 vs. control group). (C) The forward/side scatter
dot-plot profiles were analyzed from B6 mice treated
with either rat Ig (left) or EM95 (right). (D) The
CCR3 and CD3 expression was analyzed from both
the gated lymphocyte (a) and granulocyte population
(b). (E) B6 mice were injected i.p. on day  21,  14,
and  7 with 30  g rat Ig or EM95. On day 0, the
mice were injected i.p. with 30  g rat Ig or anti-IgE
sensitized i.p. with 2.5   103 inactivated S. mansoni
eggs. On day 7, the mice were challenged i.t. with
SEA. On day 11, mice were killed and analyzed. IFN- 
(E) and IL-4 levels (F) were measured from the lung
lysates (left) and BAL fluids (right) by ELISA. Similar
experiments were performed using a noncross-linking
anti-IgE antibody, R1E4 (G and H). The number of
BAL cells (G) and cytokine profiles (H) were deter-
mined as described in A and B (P   0.01; R1E4 vs.
control group). Data represent the mean   SD from a
representative experiment. Experiments were repeated
four times by different individuals with similar results.IgE Is Required for Airway Homeostasis 1650
alyzed 1 wk after the last treatment, when IgE concentra-
tions were undetectable. The total number of leukocytes in
the lung and BAL of EM95-treated WT mice increased to
the level of LT  /  mice (Fig. 5 A). A severalfold increase
of immune cells in both BAL and the lung was observed
in IgE-depleted mice. Additionally, cytokine expression
shifted from the prototypic Th2 to Th1 profile, with pro-
foundly increased IFN-  levels and reduced IL-4 in the
BAL fluid (Fig. 5 B). The percentage of lymphocyte popu-
lations in IgE-depleted WT mice (19%) increased com-
pared with mice treated with the control rat Ig (Fig. 5 C,
area a, 2.8%). After treatment, the absolute number of
CD4 , CD8 , and B220  cells increased  20-fold, result-
ing in a profile similar to LT  /  mice (unpublished data).
The granulocyte populations also increased after the anti-
IgE treatment, whereas macrophage populations were re-
duced as shown (Fig. 5 C, areas b and c). Interestingly, the
percentage of CCR3+ cells was reduced in the BAL of WT
mice treated with EM95 (Fig. 5 D). After depletion of se-
rum IgE (day  21,  14, and  7), mice were sensitized
and challenged with SEA to test if antigens that favor a Th2
response can reverse the Th1 bias resulting from the lack of
IgE. After SEA challenge, IgE-depleted mice had three- to
fivefold more leukocytes in both the lung and BAL than
WT mice or control Ig-treated mice recapitulating the in-
flammation in LT  /  mice (5.8   1.8   106 in BAL and
74   6.3   106 in the lung of anti-IgE–treated mice vs.
1.8   0.2   106 in BAL and 16   3   106 in the lung of
WT mice; P   0.001). Furthermore, the elevated Th1 cy-
tokine profile in IgE-depleted WT mice after SEA chal-
lenge reiterates the role of IgE in minimizing Th1-medi-
ated inflammation (Fig. 5, E and F).
EM95 binds both soluble IgE and surface-bound IgE
captured by Fc RI on mast cells. Cross-linking of the latter
in vitro by anti-IgE antibody has been shown to induce
mast cell degranulation and release of Th2 cytokines (8).
This side effect of EM95 is unlikely to be a confounding
factor in our system, as the treated mice show a Th1-
skewed profile, including lower IL-4 levels, despite poten-
tial anti-IgE–triggered Th2 cytokines from mast cells or
other Fc RI  cells. To avoid mast cell degranulation dur-
ing anti-IgE treatment, WT mice were treated with a dif-
ferent anti-IgE (R1E4) mAb. R1E4, which binds only se-
rum IgE via the Fc portion, is incapable of causing mast cell
degranulation via IgE cross-linking, so that after sufficient
receptor turnover and serum depletion, mast cells are inca-
pable of eliciting IgE-mediated IL-4 production (25). The
result from a short-term treatment of WT mice with R1E4
was consistent with our findings with the EM95 treatment
as follows: an increase of Th1-skewed airway inflammation
even with SEA challenge (Fig. 5, G and H). Consistently,
the total number of leukocytes increased three- to fivefold
(Fig. 5 H). T and B cells increased two- to threefold, and
macrophages increased three- to fourfold, whereas NK cells
remained unchanged (unpublished data). The data clearly
underscore the importance of IgE in balancing Th1/Th2
responses and controlling airway inflammation in response
to both environmental antigens and induced allergen.
Failure to Increase BHR to Nonspecific Challenge in LT  / 
Mice.  Increased spontaneous airway inflammation is of-
ten associated with increased BHR (3, 7, 8). To evaluate
the severity of BHR in LT  /  mice, we used intravenous
delivery of methacholine to assess airway constrictor re-
sponsiveness in anesthetized, tracheostomized, mechani-
cally ventilated mice, using the Flexivent computerized
mouse ventilator, which calculates respiratory system resis-
tance automatically. Unexpectedly, LT  /  mice with se-
vere airway inflammation failed to respond to methacho-
line challenge. LT  /  mice showed inert response to
even a high dose of mechacholine when compared with B6
mice (Fig. 6 A). The peak resistance in the bronchocon-
strictor response to various methacholine doses from all
WT mice and LT  /  mice are summarized in Fig. 6 B.
The overall response in resting LT  /  mice is lower than
that of WT mice (Fig. 6 B, P   0.001 as determined by
analysis of variance). In contrast to Th2-dominant airway
inflammation with increased BHR seen in WT mice,
LT  /  mice showed a rather distinct Th1 airway inflam-
mation with reduced BHR.
Discussion
In this paper, we have demonstrated that LT is critical
for IgE production, and that a physiological role of IgE in
the airway is to minimize Th1-dominant airway inflamma-
tion. Remarkably, the spontaneous Th1-mediated airway
inflammation phenotype of LT  /  mice, with or without
challenge, can be rescued by short-term IgE reconstitution,
Figure 6. Methacholine dose–response curves for
respiratory system resistance in a WT mouse versus an
LT  /  mouse. Invasive measurement was used to
determine respiratory system resistance in anesthetized,
tracheostomized, mechanically ventilated mice. (A) Dose-
dependent bronchoconstriction was induced by i.v.
methacholine administration to WT mice versus
LT  /  mice. (B) The peak resistance from each dose
from pooled data from three experiments was analyzed
to compare both groups (n   4; P   0.005).Kang et al. 1651
and is recapitulated in both IgE /  mice and IgE-depleted
WT mice. These findings demonstrate the indispensable
role of physiological levels of serum IgE in maintaining
lung homeostasis and BHR as well as modulating a Th1/
Th2 balance, thus providing a novel model by which to
study how IgE affects airway inflammation.
There may be multiple mechanisms responsible for the
control of the Th1/Th2 balance and airway inflammation
exerted by IgE. The ability of IgE to enhance mast cell sur-
vival and Fc RI expression in vitro has been described pre-
viously (30, 31). It is possible that reduced IgE levels in
LT  /  mice impair antigen-mediated mast cell degranula-
tion and cytokine production, such as IL-4, that are re-
quired for a Th2 response. The resulting reduction in IL-4
may lead to a Th1-dominated inflammatory response.
Whether the defect is due to mast cell maturation defects,
reduced IgE avidity on the mast cell surface, or perhaps de-
fects in other IgE binding cells remains to be investigated.
In this paper, we have demonstrated clearly that im-
paired IgE levels and increased Th1 responses occur in
LT  /  mice with or without antigen challenge. How-
ever, recent works evaluated the role of LNs in the devel-
opment of airway inflammation using LT  /  mice and
found the generation of Th2-mediated airway inflamma-
tion could still occur in LT  /  mice (20, 21). Although
baseline IgE levels have not been determined in these anal-
yses, antigen-specific IgE responses can be detectable in
OVA–GM-CSF–challenged LT  /  mice, and both Th1-
associated IFN  and Th2-associated IL-5/IL-13 were
higher in OVA–GM-CSF–challenged LT  /  mice, sug-
gesting that LNs are not essential for Th2-mediated airway
inflammation (20). Several differences may contribute to
the discrepancies between the analyses as follows. First,
OVA–GM-CSF very strongly activates the Th2 pathway
and may overcome the defect in LT  /  mice after re-
peated challenge. Second, it is possible that the relative in-
crease in IFN-  may be accountable for the dominating
Th1 response in LT  /  mice. In fact, all three models
have shown increased IFN-  levels. Third, the age of the
mice may also provide an explanation for the discrepancies
between the two analyses. 5–7-wk-old mice were used in
the previous two studies, whereas 12–16-wk-old mice
were used in our study. We have found the level of base-
line IgE is undetectable in 5–7-wk-old B6 mice but gradu-
ally elevates after 8 wk. We have also noticed that it is dif-
ficult to induce Th1-dominant airway inflammation in
5–6-wk-old LT  /  mice (unpublished data). Fourth, our
work has used freshly isolated cells from the lung, whereas
other works used restimulated splenocytes in vitro. Fur-
thermore, different antigens/adjuvant, challenge route, and
the assays for cytokine analysis may also account for poten-
tial discrepancies.
Our paper implies that a physiological role of IgE in the
lung is to minimize airway inflammation via balancing
Th1/Th2 responses. We hypothesize a possible mechanism
in which physiological levels of IgE allow controlled de-
granulation and cytokine production of mast cells or other
cells at levels required to routinely clear airway antigens
without provoking excessive inflammatory infiltration.
When IgE concentrations are excessively low, IgE-medi-
ated mast cell responses could be impaired, resulting in a
poor ability to clear the inhaled environmental antigen.
The accumulated antigens lead to the increase of infiltrates
in the lung responding to retained antigen may actually
cause tissue damage. Our paper has an impact on the recent
administration of anti-IgE in the clinic. High IgE levels
during inflammation or other pathological conditions that
favor Th2 responses or asthmatic patients with pathologi-
cally high IgE concentrations may benefit from anti-IgE
therapy in some cases. However, depletion of IgE resulting
in levels below normal may trigger a destructive Th1 in-
flammation. Conversely, there may be a subset of yet un-
recognized patients for whom lower IgE concentrations
may cause a severe Th1-mediated airway inflammation. It
will be interesting to determine whether such patients have
low IgE levels and reduced BHR. Thus, a physiological
role of IgE in the airway is required for balancing both Th1
and Th2 responses to prevent immoderate inflammation
dominated by either.
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